Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,840 | -12,858 | -6,255 | -21,151 | -13,325 |
| Depreciation Amortization | 302 | 215 | 108 | 513 | 431 |
| Accounts receivable | -1,219 | 1,203 | 98 | -2,716 | -7,491 |
| Accounts payable and accrued liabilities | -1,098 | -325 | 282 | -683 | 2,963 |
| Other Working Capital | -4,040 | -98 | -723 | -4,021 | -3,615 |
| Other Operating Activity | 5,686 | 1,173 | 240 | 5,582 | 5,943 |
| Operating Cash Flow | $-19,209 | $-10,691 | $-6,249 | $-22,477 | $-15,094 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -171 | -151 | -26 | -358 | -1,012 |
| Purchase Sale Intangibles | 300 | 300 | N/A | N/A | N/A |
| Other Investing Activity | 300 | 300 | 0 | 0 | 0 |
| Investing Cash Flow | $129 | $149 | $-26 | $-358 | $-1,012 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,000 | 3,000 | 3,000 | 14,250 | 11,250 |
| Debt Repayment | -298 | -200 | -92 | -1,196 | -772 |
| Common Stock Issued | 6,610 | 6,630 | 230 | 35,799 | 35,549 |
| Dividend Paid | -122 | -81 | -41 | -178 | -138 |
| Financing Cash Flow | $9,189 | $9,348 | $3,097 | $48,675 | $45,889 |
| Exchange Rate Effect | -6 | -17 | -10 | 107 | 77 |
| Beginning Cash Position | 30,966 | 30,966 | 30,966 | 5,018 | 5,018 |
| End Cash Position | 21,069 | 29,755 | 27,777 | 30,966 | 34,877 |
| Net Cash Flow | $-9,896 | $-1,210 | $-3,188 | $25,947 | $29,859 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,209 | -10,691 | -6,249 | -22,477 | -15,094 |
| Capital Expenditure | -171 | -151 | -26 | -358 | -1,012 |
| Free Cash Flow | -19,380 | -10,842 | -6,275 | -22,835 | -16,106 |